Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma

The proteoglycan versican (VCAN) promotes tumor progression and enhances metastasis in several cancers; however, its role in clear cell renal cell carcinoma (ccRCC) remains unknown. Recent evidence suggests that VCAN is an important target of chromosomal 5q gain, one of the most prevalent genetic ab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer Res
Main Authors: Mitsui, Yozo, Shiina, Hiroaki, Kato, Taku, Maekawa, Shigekatsu, Hashimoto, Yutaka, Shiina, Marisa, Imai-Sumida, Mitsuho, Kulkarni, Priyanka, Dasgupta, Pritha, Wong, Ryan Kenji, Hiraki, Miho, Arichi, Naoko, Fukuhara, Shinichiro, Yamamura, Soichiro, Majid, Shahana, Saini, Sharanjot, Deng, Guoren, Dahiya, Rajvir, Nakajima, Koichi, Tanaka, Yuichiro
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890926/
https://ncbi.nlm.nih.gov/pubmed/28242813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-16-0444
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados